溃疡性结肠炎联合治疗的临床观察  

The clinical observation of combination treatment of ulcerative colitis

作　　者：李晓姝[1] 

机构地区：[1]沈阳市第四人民医院,110031

出　　处：《中国实用医药》2011年第17期45-46,共2页China Practical Medicine

摘　　要：目的观察口服药物SASP结合药物灌肠联合治疗溃疡性结肠炎(UC)的疗效。方法 2009年1月至2011年3月期间该院收治住院的22例溃疡性结肠炎患者分为两组:联合治疗组11例,采用口服柳氮磺胺吡啶(SASP)+药物灌肠(思密达、地塞米松、庆大霉素)治疗;对照组11例,仅口服柳氮磺胺吡啶治疗。结果联合治疗组总有效率100.0%,对照组总有效率63.6%,两组比较差异有统计学意义(P<0.05)。结论口服药物结合药物灌肠联合治疗UC具有很好的疗效。Objective To observe the clinical effect of oral SASP drugs combined with retention-enema in patients with ulcerative colitis. Methods 22 cases of hospitalized patients of ulcerative colitis in the hospital from January 2009 to March 2011 were selected and randomly divided into two groups. The treatment group：11 cases, treated by oral drugs（SASP）combined with retention-enema（Smecta、Dexamethasone、Gentamicin）. The control group, 11 cases, treated by oral SASP drugs only. Results The total effective rate of treatment group was 100.0 %, the total effective rate of control group was 63.6%. there were difference in the two groups（P〈0.05）.Conclusion Oral SASP drugs combined with retention-enema in the treatment of ulcerative colitis is more effective.

关 键 词：溃疡性结肠炎 治疗 临床观察 

分 类 号：R574.62[医药卫生—消化系统]